Temporal trends in the characteristics of children at antiretroviral therapy initiation in Southern Africa: The IeDEA-SA collaboration

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Davies, Mary Ann ^a   Phiri, Sam ^b   Wood, Robin ^a   Wellington, Maureen ^c   Cox, Vivian ^d   Bolton Moore, Carolyn ^e,f   Timmerman, Venessa ^g   Moultrie, Harry ^h   Ndirangu, James ⁱ   Rabie, Helena ^j   Technau, Karl ^k   Giddy, Janet ^l   Maxwell, Nicola ^a   Boulle, Andrew ^a   Keiser, Olivia ^m   Egger, Matthias ^m   Eley, Brian ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b KAMUZU CENTRAL HOSPITAL   (Malawi)

^c Newlands Clinic   (Zimbabwe)

^d MÉDECINS SANS FRONTIÈRES   (Switzerland)

^e CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁱ UNIVERSITY OF KWAZULU NATAL   (South Africa)

^j STELLENBOSCH UNIVERSITY   (South Africa)

^k UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^l MCCORD HOSPITAL   (South Africa)

^m UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; ANEMIA; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MORTALITY; SOUTH AFRICA;

AFRICA, SOUTHERN; ANEMIA; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; LOGISTIC MODELS; MALE; TIME FACTORS;

EID: 84892587086     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081037     Document Type: Article

References (58)

1. WHO (2011) Global HIV/AIDS Response. Epidemic update and health sector progress towards Universal Access. Progress Report 2011.
2. WHO (2010) Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Recommendations for a public health approach: 2010 revision.
3. Heidari S, Mofenson LM, Hobbs CV, Cotton MF, Marlink R, et al. (2012) Unresolved antiretroviral treatment management issues in HIV-infected children. Journal of Acquired Immune Deficiency Syndromes 59: 161-169.
4. Calmy A, Ford N (2011) Improving treatment outcomes for children with HIV. Lancet 377: 1546-1548.
5. Little K, Thorne C, Luo C, Bunders M, Ngongo N, et al. (2007) Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment. Current HIV Research 5: 139-153.
6. Becquet R, Marston M, Dabis F, Moulton LH, Gray G, et al. (2012) Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis. PLoS One 7: e28510.
7. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ (2008) Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infectious Diseases 8: 477-489.
8. Peacock-Villada E, Richardson BA, John-Stewart GC (2011) Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries. Pediatrics 127: e423-441.
9. Davies M, Keiser O, Technau K, Eley B, Rabie H, et al. (2009) Outcomes of the South African National Antiretroviral Treatment (ART) programme for children - The IeDEA Southern Africa Collaboration. South African Medical Journal 99: 730-737.
10. Eley B, Davies MA, Apolles P, Cowburn C, Buys H, et al. (2006) Antiretroviral treatment for children. South African Medical Journal 96: 988-993.
11. Zanoni BC, Phungula T, Zanoni HM, France H, Cook EF, et al. (2012) Predictors of poor CD4 and weight recovery in HIV-infected children initiating ART in South Africa. PLoS One 7: e33611.
12. Laughton B, Cornell M, Grove D, Kidd M, Springer PE, et al. (2012) Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS 26: 1685-1690.
13. Fatti G, Bock P, Eley B, Mothibi E, Grimwood A (2011) Temporal trends in baseline characteristics and treatment outcomes of children starting antiretroviral treatment: an analysis in four provinces in South Africa, 2004-2009. Journal of Acquired Immune Deficiency Syndromes 58: e60-67.
14. Sutcliffe CG, Bolton-Moore C, van Dijk JH, Cotham M, Tambatamba B, et al. (2010) Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study. BMC Pediatrics 10: 54.
15. Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, et al. (2010) Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS 24: 2263-2270.
16. Patel SD, Larson E, Mbengashe T, O'Bra H, Brown JW, et al. (2012) Increases in pediatric antiretroviral treatment, South Africa 2005-2010. PLoS One 7: e44914.
17. Cornell M, Technau K, Fairall L, Wood R, Moultrie H, et al. (2009) Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. South African Medical Journal 99: 653-660.
18. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, et al. (2008) Early antiretroviral therapy and mortality among HIV-infected infants. New England Journal of Medicine 359: 2233-2244.
19. WHO (2008) Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Meeting.
20. Fenner L, Brinkhof M, Keiser O, Weigel R, Cornell M, et al. (2010) Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. Journal of Acquired Immune Deficiency Syndromes 54: 524-532.
21. WHO (2006) The WHO Child Growth Standards. WHO.
22. WHO (2006) Antiretroviral therapy of HIV infection in infants and children: towards universal access. Switzerland: WHO.
23. Division of AIDS (2009) Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events Version 1.0, December 2004; Clarification August 2009.
24. Malawi Ministry of Health (2006) Guidelines for the use of anitretroviral therapy in Malawi - 2nd edition: Malawi Ministry of Health.
25. National Department of Health of South Africa (2010) Guidelines for the Management of HIV in Children, 2nd Edition, 2010.
26. National Department of Health South Africa (2004) National Antiretroviral Treatment Guidelines. Jacana.
27. National Department of Health South Africa (2005) Guidelines for the management of HIV-infected children in South Africa. Jacana.
28. Malawi Ministry of Health (2008) Guidelines for the use of antiretroviral therapy in Malawi - 3rd edition: Malawi Ministry of Health.
29. Malawi Ministry of Health (2011) Clinical management of HIV in children and adults. Lilongwe: Malawi Ministry of Health.
30. National Department of Health of South Africa (2012) Circular minute 2 of 2012: Initiation of antiretroviral treatment to all HIV positive children aged 5 years and under regardless of CD4 count and/or WHO clinical staging. Pretoria.
31. Jaspan HB, Berrisford AE, Boulle AM (2008) Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program. Pediatric Infectious Disease Journal 27: 993-998.
32. Kiboneka A, Wangisi J, Nabiryo C, Tembe J, Kusemererwa S, et al. (2008) Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS 22: 2493-2499.
33. Anaky MF, Duvignac J, Wemin L, Kouakoussui A, Karcher S, et al. (2010) Scaling up antiretroviral therapy for HIV-infected children in Cote d'Ivoire: determinants of survival and loss to programme. Bulletin of the World Health Organization 88. 490-499.
34. Janssen N, Ndirangu J, Newell ML, Bland RM (2010) Successful paediatric HIV treatment in rural primary care in Africa. Archives of Diseases in Childhood 95: 414-421.
35. Fatti G, Bock P, Grimwood A, Eley B (2010) Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study. Journal of the International AIDS Society 13: 46.
36. Sutcliffe CG, van Dijk JH, Bolton-Moore C, Cotham M, Tambatamba B, et al. (2010) Differences in presentation, treatment initiation, and response among children infected with human immunodeficiency virus in urban and rural Zambia. Pediatric Infectious Disease Journal 29: 849-854.
37. Braitstein P, Songok J, Vreeman RC, Wools-Kaloustian KK, Koskei P, et al. (2011) "Wamepotea" (they have become lost): outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya. Journal of Acquired Immune Deficiency Syndromes 57: e40-46.
38. McGuire M, Munyenyembe T, Szumilin E, Heinzelmann A, Le Paih M, et al. (2010) Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Tropical Medicine and International Health 15 Suppl 1: 55-62.
39. Ferrand RA, Corbett EL, Wood R, Hargrove J, Ndhlovu CE, et al. (2009) AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS 23: 2039-2046.
40. Ferrand RA, Bandason T, Musvaire P, Larke N, Nathoo K, et al. (2010) Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey. PLoS Medicine 7: e1000178.
41. Gray GE (2010) Adolescent HIV-cause for concern in Southern Africa. PLoS Medicine 7: e1000227.
42. Ferrand R, Lowe S, Whande B, Munaiwa L, Langhaug L, et al. (2010) Survey of children accessing HIV services in a high prevalence setting: time for adolescents to count? Bulletin of the World Health Organization 88: 428-434.
43. Ferrand RA, Munaiwa L, Matsekete J, Bandason T, Nathoo K, et al. (2010) Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe. Clinical Infectious Diseases 51: 844-851.
44. Weigel R, Kamthunzi P, Mwansambo C, Phiri S, Kazembe PN (2009) Effect of provider-initiated testing and counselling and integration of ART services on access to HIV diagnosis and treatment for children in Lilongwe, Malawi: a prepost comparison. BMC Pediatrics 9: 80.
45. Rollins N, Mzolo S, Moodley T, Esterhuizen T, van Rooyen H (2009) Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings. AIDS 23: 1851-1857.
46. WHO (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.
47. Iliff P, Ntozini R, Nathoo K, Piwoz E, Moulton L, et al. (2008) Making a working clinical diagnosis of HIV infection in infants in Zimbabwe. Tropical Medicine and International Health 13: 1459-1469.
48. Inwani I, Mbori-Ngacha D, Nduati R, Obimbo E, Wamalwa D, et al. (2009) Performance of clinical algorithms for HIV-1 diagnosis and antiretroviral initiation among HIV-1-exposed children aged less than 18 months in Kenya. Journal of Acquired Immune Deficiency Syndromes 50: 492-498.
49. Khamadi S, Okoth V, Lihana R, Nabwera J, Hungu J, et al. (2008) Rapid identification of infants for antiretroviral therapy in a resource poor setting: the Kenya experience. Journal of Tropical Pediatrics 54: 370-374.
50. Braun M, Kabue MM, McCollum ED, Ahmed S, Kim M, et al. (2011) Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi. Journal of Acquired Immune Deficiency Syndromes 56: e122-128.
51. Meyers T, Moultrie H, Naidoo K, Cotton M, Eley B, et al. (2007) Challenges to pediatric HIV care and treatment in South Africa. Journal of Infectious Diseases 196 Suppl 3: S474-S481.
52. Kankasa C, Carter RJ, Briggs N, Bulterys M, Chama E, et al. (2009) Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility. Journal of Acquired Immune Deficiency Syndromes 51: 202-208.
53. Mutanga JN, Raymond J, Towle MS, Mutembo S, Fubisha RC, et al. (2012) Institutionalizing provider-initiated HIV testing and counselling for children: an observational case study from Zambia. PLoS One 7: e29656.
54. Nuwagaba-Biribonwoha H, Werq-Semo B, Abdallah A, Cunningham A, Gamaliel JG, et al. (2010) Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in Tanzania. BMC Pediatrics 10: 44.
55. Lilian RR, Kalk E, Bhowan K, Berrie L, Carmona S, et al. (2012) Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age. Journal of Clinical Microbiology 50: 2373-2377.
56. Bourne DE, Thompson M, Brody LL, Cotton M, Draper B, et al. (2009) Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS 23: 101-106.
57. Violari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, et al. (2012) Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. New England Journal of Medicine 366: 2380-2389.
58. Chakanyuka-Musanhu CC, Penazzato M, Apollo T, Dzangare J, Mtapuri-Zinyowera S, et al. (2013) World Health Organization HIV drug resistance surveillance in children less than 18 months newly diagnosed with HIV in Zimbabwe. 7th International AIDS Society Conference. Kuala Lumpur, Malaysia.